OCEA Ocean Biomedical Inc Net earnings per share growth forecast for next year
Ocean Biomedical, Inc. (OCEA) is optimizing costs by outsourcing production and clinical trials to third-party contractors. The company leverages licensed university patents, creating long-term potential for royalty streams. Its business model functions as a commercialization ecosystem for developments under FDA supervision. The forward EPS forecast for the coming year on GURU.Markets contains the value 0.00, which captures the current state of the parameter.
Analytical breakdowns for Ocean Biomedical, Inc.
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
Total Debt to Capital Ocean Biomedical, Inc.|OCEA - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Ocean Biomedical|OCEA - Company Cumulative Debt|Debts to Book Capitalization Ocean Biomedical|OCEA - Company Long-Term Debts|Company Short-Term Debt Ocean Biomedical|Quick Liquidity Indicator oceanbiomedical.com
- earnings and valuation multiples information:
OCEA - Final Profit|Projected Future Earnings Ocean Biomedical, Inc.|OCEA - Price to Earnings Ratio|Forward P/E Multiple Ocean Biomedical, Inc.|OCEA - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Ocean Biomedical|OCEA - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Ocean Biomedical|OCEA - Net earnings per share for the last 12 months|Quarterly EPS earnings growth oceanbiomedical.com|OCEA - Earnings per share growth rate in current year|Earnings growth forecast for next year Ocean Biomedical, Inc.
- total revenue and sales volume data:
Fundamental company analysis:Ocean Bio, OCEA
The commercialization of immunology patents and the success of clinical trials at Ocean Biomedical, Inc. (OCEA) determine future profitability, which is reflected in the dynamics of expected earnings per share. This target for next year's EPS growth rate on GURU.Markets measures the analysts' consensus forecast, helping investors assess the sustainability of fundamental value and avoid impulsive trades when the indicator moves beyond normal boundaries.
Main competitors
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year BioNTech Pharma|Net earnings per share growth forecast for next year Abivax (ABVX)|admabiologics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (Protagonist)|Immunovant Inc (IMVT) - Expected net earnings per share growth next year|KNSA - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Grifols Biemat|ADPT: Earnings growth forecast for next year|Expected earnings per share growth for next year celldex.com|AUPH (Aurinia Pharmaceuticals Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year BioCryst Pharmaceuticals, Inc. BCRX|Earnings growth forecast for next year VERA|Earnings growth forecast for next year Dianthus Corp (DNTH)|Net earnings per share growth forecast for next year Pharvaris N.V. PHVS|ABCL: Projected earnings per share growth rate for next year|TRML: Expected earnings per share growth for next year|Expected earnings per share trend next year PGEN (Precigen Inc)|PHAR: Earnings growth forecast for next year|NKTR (Nektar Corp) - Net earnings per share growth forecast for next year|UPB (Upstream Bio Inc) - Earnings growth forecast for next year|zenasbio.com (ZBIO) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Immunome (IMNM)|GOSS - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year KalVista Pharmaceuticals Inc KALV|SEPN - Expected earnings per share growth for next year|Pieris Pharmaceuticals - Earnings growth forecast for next year|Expected net earnings per share growth next year savarapharma.com|RIGL: Earnings growth forecast for next year|Projected earnings per share growth rate for next year ANAB|ATXS (Astria Pharma) - Earnings growth forecast for next year|enGene Corp (ENGN) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year RAPT|Expected earnings per share growth for next year aerovatetx.com JBIO|Earnings growth forecast for next year ACRS (Aclaris Therapeutics, Inc.)|Earnings growth forecast for next year Kyverna Therapeutics Inc. KYTX|TLSA - Net earnings per share growth forecast for next year|CABA: Net earnings per share growth forecast for next year|VTYX (Ventyx Biosciences) - Expected earnings per share growth for next year|theratech.com - Expected earnings per share trend next year|AVTX (Avalo Therapeutics) - Earnings growth forecast for next year|Eledon Pharmaceuticals Inc. (ELDN) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Agenus Inc (AGEN)|Climb Bio, Inc - Projected earnings per share growth rate for next year|Earnings growth forecast for next year ZURA (Zura Bio Limited)|ATYR - Expected earnings per share growth for next year|ADAG: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year ImageneBio Inc IMA|shattucklabs.com (STTK) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Equillium (EQ)|CNTB (Connect Biopharma Holdings) - Earnings growth forecast for next year|Expected earnings per share growth for next year Immunic Inc (IMUX)|Earnings growth forecast for next year ATRA|IFRX - Expected net earnings per share growth next year|Earnings growth forecast for next year XFOR (X4 Pharma)|Earnings growth forecast for next year Adicet Bio Inc. ACET|CELU - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year INMB|BRNS: Earnings growth forecast for next year|Kezar Life Sciences Inc. - Expected earnings per share trend next year|SABS (SAB Biotherapeutics, Inc) - Earnings growth forecast for next year|Earnings growth forecast for next year Akari Therapeutics, Plc|Net earnings per share growth forecast for next year Enlivex Therapeutics (ENLV)|QTTB (q32bio.com) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year GeoVax GOVX|EDSA - Expected earnings per share growth for next year|iBio Corp - Earnings growth forecast for next year|CARM - Earnings growth forecast for next year|XTLB (XTL Biopharmaceuticals) - Expected earnings per share growth for next year|Bolt Biotherapeutics, Inc. - Expected earnings per share trend next year|HCWB (HCW Biologics, Inc.) - Earnings growth forecast for next year|Aptevo (APVO) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year AIM ImmunoTech (AIM)|Expected earnings per share growth for next year aditxt.com ADTX|Net earnings per share growth forecast for next year GRI Bio, Inc. GRI|XRTX - Expected earnings per share growth for next year|HIND: Expected earnings per share growth for next year|REVB - Earnings growth forecast for next year|Indaptus (INDP) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year SCNI|CALI (CalciMedica Inc) - Earnings growth forecast for next year|Expected net earnings per share growth next year Affimed Therapeutics AFMD|Net earnings per share growth forecast for next year Allakos Inc. (ALLK)|HOOK - Expected net earnings per share growth next year|Earnings growth forecast for next year IGMS (IGM Biosciences)|ITOS - Expected earnings per share growth for next year|TC Biopharm - Earnings growth forecast for next year|Expected net earnings per share growth next year thirdharmonicbio.com
